Below are examples of pancreatic cancer trials being conducted by the Alliance for Clinical Trials in Oncology: A021501: This randomized phase II trial studies how well combination chemotherapy (mFOLFIRINOX) with or without hypofractionated radiation therapy before surgery works in patients
The Alliance A021101 trial is a phase II clinical trial designed to investigate the use of neoadjuvant chemotherapy followed by surgery for patients with borderline resectable pancreatic cancer. Borderline resectable pancreatic cancer is a type of pancreatic cancer that is
Alliance A021501 is a phase 2 randomized clinical trial that compares the efficacy of neoadjuvant modified FOLFIRINOX with or without hypofractionated radiation therapy for borderline resectable adenocarcinoma of the pancreas.1 The trial was led by the Alliance for Clinical Trials in Oncology with
Alliance A021806 is a Phase III trial that aims to evaluate the efficacy of perioperative chemotherapy with mFOLFIRINOX in patients with resectable pancreatic cancer.1, 2 The study is actively accruing randomized controlled phase III trial evaluating the efficacy of perioperative chemotherapy with mFOLFIRINOX
The Alliance for Clinical Trials in Oncology, commonly referred to as simply the Alliance, is a cooperative group of researchers and healthcare professionals dedicated to improving the treatment and outcomes for patients with cancer. The Alliance conducts clinical trials to